Avanos Medical Chairman Buys 84% More Shares Amid Low Insider Ownership
PorAinvest
domingo, 17 de agosto de 2025, 8:52 am ET1 min de lectura
AVNS--
The purchase price of $10.99 per share is slightly above the company's average trading price of $10.975 for the day, indicating a potential optimism from Blackford regarding Avanos Medical's future prospects. This is the largest insider purchase in the past year, suggesting that Blackford and possibly other insiders are bullish on the company's performance.
Despite the insider buying, Avanos Medical's insider ownership remains relatively low at 1.8%, according to the latest SEC filings. The company's stock has been trading up about 0.7% on Friday, August 15, 2025, following the insider purchase [2].
However, it is important to note that Avanos Medical did not report a profit in the last 12 months, which could be a concern for investors. The company's financial performance and the reasons behind the insider buying will need to be closely monitored to gauge the impact on the stock price.
References:
[1] https://www.stocktitan.net/sec-filings/AVNS/form-4-avanos-medical-inc-insider-trading-activity-306515f62405.html
[2] https://www.nasdaq.com/articles/friday-8-15-insider-buying-report-psx-avns
Gary Blackford, Independent Chairman of Avanos Medical, recently bought 84% more shares for $659k at $10.99, boosting their holding. This is the largest insider purchase in the last year and implies optimism about the company. However, insider ownership is low at 1.8%, and the company did not make a profit in the last 12 months.
Independent Chairman Gary Blackford of Avanos Medical, Inc. (AVNS) recently made a notable insider purchase, buying an additional 60,000 shares at a cost of $10.99 each, totaling $659,300. This transaction, reported on August 13, 2025, represents a significant increase in Blackford's holding, boosting his stake by 84% [1].The purchase price of $10.99 per share is slightly above the company's average trading price of $10.975 for the day, indicating a potential optimism from Blackford regarding Avanos Medical's future prospects. This is the largest insider purchase in the past year, suggesting that Blackford and possibly other insiders are bullish on the company's performance.
Despite the insider buying, Avanos Medical's insider ownership remains relatively low at 1.8%, according to the latest SEC filings. The company's stock has been trading up about 0.7% on Friday, August 15, 2025, following the insider purchase [2].
However, it is important to note that Avanos Medical did not report a profit in the last 12 months, which could be a concern for investors. The company's financial performance and the reasons behind the insider buying will need to be closely monitored to gauge the impact on the stock price.
References:
[1] https://www.stocktitan.net/sec-filings/AVNS/form-4-avanos-medical-inc-insider-trading-activity-306515f62405.html
[2] https://www.nasdaq.com/articles/friday-8-15-insider-buying-report-psx-avns

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios